Evidence map›Paper›PMID 42859497›Full record

ArticleJournal of hip preservation surgery2026

Challenging age limits: favourable mid-term outcomes of periacetabular osteotomy in patients over 30 years of age with borderline hip dysplasia.

Maximilian Fischer, Andreas Nitsch, Alexander Möller, Andre Hofer, Georgi I Wassilew

Abstract read
In one paragraph

Article in Journal of hip preservation surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maximilian FischerCenter for Orthopaedics, Trauma Surgery and Rehabilitation Medicine, University Medicine Greifswald, Ferdinand-Sauerbruch Straße, Greifswald 17475, Germany.ORCID https://orcid.org/0009-0003-1567-5297
Andreas NitschCenter for Orthopaedics, Trauma Surgery and Rehabilitation Medicine, University Medicine Greifswald, Ferdinand-Sauerbruch Straße, Greifswald 17475, Germany.
Alexander MöllerCenter for Orthopaedics, Trauma Surgery and Rehabilitation Medicine, University Medicine Greifswald, Ferdinand-Sauerbruch Straße, Greifswald 17475, Germany.
Andre HoferCenter for Orthopaedics, Trauma Surgery and Rehabilitation Medicine, University Medicine Greifswald, Ferdinand-Sauerbruch Straße, Greifswald 17475, Germany.
Georgi I WassilewCenter for Orthopaedics, Trauma Surgery and Rehabilitation Medicine, University Medicine Greifswald, Ferdinand-Sauerbruch Straße, Greifswald 17475, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The treatment of borderline hip dysplasia (BHD) remains controversial, with a paucity of literature on whether periacetabular osteotomy (PAO) is a viable option even in middle-aged patients over 30 years of age. This study aimed to analyse the functional outcome and activity level in relation to the patient's age after PAO for BHD. Patients over 30 years of age (G30-age 30-40; G40 age > 40) undergoing PAO for BHD were enrolled in this single-centre study with a minimum follow-up of 2 years. The patient-reported outcomes (PRO) were assessed using the numeric rating scale (NRS) for pain, the modified Harris-Hip score (mHHS), and International Hip Outcome Tool-12 (iHot-12) for joint functionality, and the University of California Los Angeles activity score (UCLA) for sports participation. Forty-eight patients (48 hips) were included. There was a significant postoperative pain relief in both groups (G30 pre-post 7.2 - 2.7,

Indexed as

ageborderline hip dysplasiadevelopmental dysplasia of the hippatient-reported outcomesperiacetabular osteotomy

Identifiers

PMID42859497
PMCPMC13653065

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.